| [1] |
MEDINA JF. Role of the anion exchanger 2 in the pathogenesis and treatment of primary biliary cirrhosis[J]. Dig Dis, 2011, 29(1): 103-112. DOI: 10.1159/000324144 |
| [2] |
SASAKI M, SATO Y, NAKANUMA Y. An impaired biliary bicarbonate umbrella may be involved in dysregulated autophagy in primary biliary cholangitis[J]. Lab Invest, 2018, 98(6): 745-754. DOI: 10.1038/s41374-018-0045-4 |
| [3] |
DEUTSCHMANN K, REICH M, KLINDT C, et al. Bile acid receptors in the biliary tree: TGR5 in physiology and disease[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B): 1319-1325. http://www.ncbi.nlm.nih.gov/pubmed/28844960 |
| [4] |
BEUERS U, HOHENESTER S, MAILLETTE BW, et al. The biliary HCO 3- umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosingcholangiopathies[J]. Hepatology, 2010, 52(4): 1489-1496. DOI: 10.1002/hep.23810 |
| [5] |
MAILLETTE de BUY WENNIGER LJ, HOHENESTER S, MARONI L, et al. The cholangiocyte glycocalyx stabilizes the 'biliary HCO 3 umbrella': An integrated line of defense against toxic bile acids[J]. Dig Dis, 2015, 33(3): 397-407. DOI: 10.1159/000371864 |
| [6] |
HOHENESTER S, WENNIGER LM, PAULUSMA CC, et al. A biliary HCO 3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes[J]. Hepatology, 2012, 55(1): 173-183. DOI: 10.1002/hep.24691 |
| [7] |
LI M, CAI SY, BOYER JL. Mechanisms of bile acid mediated inflammation in the liver[J]. Mol Aspects Med, 2017, 56: 45-53. DOI: 10.1016/j.mam.2017.06.001 |
| [8] |
THAKKAR N, SLIZGI JR, BROUWER K. Effect of liver disease on hepatic transporter expression and function[J]. J Pharm Sci, 2017, 106(9): 2282-2294. DOI: 10.1016/j.xphs.2017.04.053 |
| [9] |
van NIEKERK J, KERSTEN R, BEUERS U. Role of bile acids and the biliary HCO 3- umbrella in the pathogenesis of primary biliary cholangitis[J]. Clin Liver Dis, 2018, 22(3): 457-479. DOI: 10.1016/j.cld.2018.03.013 |
| [10] |
BOYER JL. Bile formation and secretion[J]. Compr Physiol, 2013, 3(3): 1035-1078.
|
| [11] |
WU N, MENG F, ZHOU T, et al. The secretin/secretin receptor axis modulates ductular reaction and liver fibrosis through changes in transforming growth factor-β1-mediated biliary senescence[J]. Am J Pathol, 2018, 188(10): 2264-2280. DOI: 10.1016/j.ajpath.2018.06.015 |
| [12] |
MINAGAWA N, NAGATA J, SHIBAO K, et al. Cyclic AMP regulates bicarbonate secretion in cholangiocytes through release of ATP into bile[J]. Gastroenterology, 2007, 133(5): 1592-1602. DOI: 10.1053/j.gastro.2007.08.020 |
| [13] |
TIETZ PS, MARINELLI RA, CHEN XM, et al. Agonist-induced coordinated traffickingof functionally related transport proteins for water and ions in cholangiocytes[J]. J Biol Chem, 2003, 278(22): 20413-20419. DOI: 10.1074/jbc.M302108200 |
| [14] |
STEEGBORN C. Structure, mechanism, and regulation of soluble adenylyl cyclases-similarities and differences to transmembrane adenylyl cyclases[J]. Biochim Biophys Acta, 2014, 1842(12 Pt B): 2535-2547. http://europepmc.org/abstract/med/25193033 |
| [15] |
PRIETO J, GARCÍA N, MARTÍ-CLIMENT JM, et al. Assessment of biliary bicarbonate secretion in humans by positron emission tomography[J]. Gastroenterology, 1999, 117(1): 167-172. DOI: 10.1016/S0016-5085(99)70564-0 |
| [16] |
JURAN BD, LAZARIDIS KN. Update on the genetics and genomics of PBC[J]. J Autoimmun, 2010, 35(3): 181-187. DOI: 10.1016/j.jaut.2010.06.005 |
| [17] |
KOUROUMALIS E, SAMONAKIS D, VOUMVOURAKI A. Biomarkers for primary biliary cholangitis: Current perspectives[J]. Hepat Med, 2018, 10: 43-53. DOI: 10.2147/HMER.S135337 |
| [18] |
ARENAS F, HERVÍAS I, SÁEZ E, et al. Promoter hypermethylation of the AE2/SLC4A2 gene in PBC[J]. JHEP Rep, 2019, 1(3): 145-153. DOI: 10.1016/j.jhepr.2019.05.006 |
| [19] |
ERICE O, MUNOZ-GARRIDO P, VAQUERO J, et al. MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation[J]. Hepatology, 2018, 67(4): 1420-1440. DOI: 10.1002/hep.29533 |
| [20] |
|
| [21] |
KLEINBOELTING S, DIAZ A, MONIOT S, et al. Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate[J]. Proc Natl Acad Sci U S A, 2014, 111(10): 3727-3732. DOI: 10.1073/pnas.1322778111 |
| [22] |
CHANG JC, GO S, de WAART DR, et al. Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes[J]. Hepatology, 2016, 64(2): 522-534. DOI: 10.1002/hep.28550 |
| [23] |
CHANG JC, GO S, VERHOEVEN AJ, et al. Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; A new hypothesis[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B): 1232-1239. http://europepmc.org/abstract/MED/28962898 |
| [24] |
FUKUI H. Increased intestinal permeability and decreased barrier function: Does it really influence the risk of inflammation?[J]. Inflamm Intest Dis, 2016, 1(3): 135-145. DOI: 10.1159/000447252 |
| [25] |
KIZILTAS S. Toll-like receptors in pathophysiology of liver diseases[J]. World J Hepatol, 2016, 8(32): 1354-1369. DOI: 10.4254/wjh.v8.i32.1354 |
| [26] |
ZHU M, AN Y, ZHANG X, et al. Experimental pulmonary fibrosis was suppressed by microRNA-506 through NF-kappa-mediated apoptosis and inflammation[J]. Cell Tissue Res, 2019, 378(2): 255-265. DOI: 10.1007/s00441-019-03054-2 |
| [27] |
FRANCA A, CARLOS MELO LIMA FILHO A, GUERRA MT, et al. Effects of endotoxin on type 3 inositol 1, 4, 5-trisphosphate receptor in human cholangiocytes[J]. Hepatology, 2019, 69(2): 817-830. DOI: 10.1002/hep.30228 |
| [28] |
TSUBOI H, OHIRA H, ASASHIMA H, et al. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with primary biliary cirrhosis[J]. Hepatol Res, 2014, 44(14): e471-e479. DOI: 10.1111/hepr.12346 |
| [29] |
|
| [30] |
SAMANT H, MANATSATHIT W, DIES D, et al. Cholestatic liver diseases: An era of emerging therapies[J]. World J Clin Cases, 2019, 7(13): 1571-1581. DOI: 10.12998/wjcc.v7.i13.1571 |
DownLoad: